News from pao group, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 10, 2021, 09:51 ET PAOG and PURA Announce Women's Health CBD Product Partnership

PAO Group, Inc. (USOTC: PAOG) and Puration, Inc. (USOTC: PURA) today announced the companies will partner on the development of a line of CBD...

Nov 02, 2021, 12:40 ET PAOG Initiates Second CBD Nutraceutical Production Run As Early Results Of First Run Indicate Sell Out

PAO Group, Inc. (USOTC: PAOG) today announced initiating a second production run of the first CBD nutraceuticals products the company recently...

Oct 27, 2021, 09:56 ET PAOG Expands CBD Footprint Into Market Forecasted To Reach Over $29 Billion

PAO Group, Inc. (USOTC: PAOG) today cited recent CBD market analysis from Technavio forecasting the CBD market to reach $29.91 billion by 2025...

Oct 26, 2021, 11:53 ET PAOG Plans To Accelerate 2022 CBD Revenue Growth Through M&A

PAO Group, Inc. (USOTC: PAOG) today announced the company's merger and acquisition development pipeline supports plans for a first acquisition to...

Oct 21, 2021, 12:42 ET PAOG Builds CBD "RX" Brand Now Introducing 2nd CBD Product

PAO Group, Inc. (USOTC: PAOG) today announced the launch of its second CBD nutraceutical product, RehabRX CBD, in a line of coming CBD products under ...

Oct 20, 2021, 12:41 ET PAOG Announces CBD Pet Products Coming Soon To $100 Billion Market

PAO Group, Inc. (USOTC: PAOG) today revealed the company has been working on the development of CBD products for pets and could have its first...

Oct 18, 2021, 11:58 ET PAOG Announces New CBD Nutraceutical Targeting $100 Billion Sleep Aid Market

PAO Group, Inc. (USOTC: PAOG) today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. RelaxRX is available in...

Oct 15, 2021, 09:25 ET PAOG Cites New British Medical Journal Case Report On CBD Lung Cancer And COPD Treatment As Validation Of PAOG Ongoing RespRx Drug Research

PAO Group, Inc. (USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung...

Oct 14, 2021, 08:59 ET PAOG RespRx CBD Pharmaceutical Respiratory Treatment In The Spotlight

PAO Group, Inc. (USOTC: PAOG) today announced encountering a flurry of outside interest of late into the company's CBD pharmaceutical respiratory...

Oct 12, 2021, 11:12 ET PAOG Announces Imminent Launch Of First CBD Nutraceutical Product Line - Q4 Sales Projected With Rapid Revenue Growth Anticipated To Follow

PAO Group, Inc. (USOTC: PAOG) today announced the company expects to realize its first CBD nutraceutical product sales beginning imminently in Q4,...

Oct 08, 2021, 10:04 ET PAOG Ships First CBD Nutraceutical Product To USMJ For Distribution

PAO Group, Inc. (USOTC: PAOG) today announced shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis...

Oct 05, 2021, 10:22 ET PAOG To Build On CBD Business Through Acquisition

PAO Group, Inc. (USOTC: PAOG) today announced the company is actively exploring merger and acquisition opportunities targeted at expanding the...

May 13, 2021, 14:10 ET PAOG Introduces International Approach To Targeting $5 Billion CBD Nutraceutical Market

PAO Group, Inc. (USOTC: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products. The 2020 ...

May 07, 2021, 09:04 ET PAOG Partners With PURA, ALKM and USMJ To Launch CBD Nutraceutical Product Line

PAO Group, Inc. (USOTC: PAOG) today released a preview of the company's plan to launch a CBD Nutraceuticals line of products. PAOG's CBD...

May 06, 2021, 12:05 ET PAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership Highlights

PAO Group, Inc. (USOTC: PAOG) today highlighted that the upcoming CBD Nutraceutical Sales Rollout Presentation scheduled for tomorrow, Friday, May 7, ...

Apr 13, 2021, 09:23 ET PAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction Technology

PAO Group, Inc. (USOTC: PAOG) today released a management update on the company's ongoing CBD Pharmaceutical Development Program. Last year, PAOG...

Apr 12, 2021, 11:40 ET PAOG To Publish Latest CBD Pharmaceutical Developments Tomorrow, Tuesday April 13, 2021

PAO Group, Inc. (USOTC: PAOG) today confirmed a management update on the company's ongoing CBD Pharmaceutical Development Program progress scheduled...

Apr 08, 2021, 09:42 ET PAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On Track

PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company's ongoing CBD Pharmaceutical Development Program progress scheduled...

Mar 09, 2021, 12:18 ET PAOG CBD RELAX-RX Nutraceutical Plans To Co-Pack With ALKM And Market With USMJ Detailed In Update Scheduled Next Week

PAO Group, Inc. (USOTC: PAOG) today announced an update scheduled one week from today, for Tuesday, March 16, 2021 to publish details on the...

Feb 18, 2021, 11:08 ET PAOG Expects To Add CBD Nutraceuticals Revenue This Year

PAO Group, Inc. (USOTC: PAOG) today highlighted the company's anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier...

Feb 09, 2021, 12:17 ET PAOG Confirms CBD Pharmaceutical And Nutraceutical Product Development Presentation Schedule

PAO Group, Inc. (USOTC: PAOG) today confirmed plans to publish a multimedia presentation next week on the company's strategy to expand its...

Feb 04, 2021, 09:27 ET PAOG To Extend CBD Nutraceuticals Reach Into $3.8 Billion Market

PAO Group, Inc. (USOTC: PAOG) today revealed plans to expand its nutraceutical product reach. The company plans to produce nutraceuticals for...

Feb 03, 2021, 10:59 ET PAOG Highlights Its Own Cannabis Pharma Tech As GW Pharma Valued At $7.2 B

PAO Group, Inc. (USOTC: PAOG) today highlighted its own proprietary, U.S. Patent backed, cannabis pharmaceutical technology in light of the...

Feb 03, 2021, 08:00 ET PAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation Subsidiary

PAO Group, Inc. (USOTC: PAOG) today announced the company anticipates reporting an estimated $50,000 in revenue for Q4 2020. The revenue is...

Jan 27, 2021, 12:56 ET PAOG CBD Nutraceuticals Underdevelopment To Be Distributed Through USMJ

PAO Group, Inc. (USOTC: PAOG) today announced moving forward with its initiative to produce cannabis nutraceuticals. PAOG added that the...